Minakem is a company operating in the pharmaceutical industry.
MINAKEM is specialized in custom manufacturing of complex, advanced intermediates and APIs and HAPIs under strict cGMP conditions for the pharmaceutical industry. All development and manufacturing activities are supported by highly skilled R&D technical centres, strong and state-of-the-art analytical services including solid form and QbD laboratories. The R&D team is dedicated to process development, organic synthesis and analysis, and works under a secrecy agreement. The total capacity of its multi-purpose plant (FDA inspected) is 290m3. Minakem performs reactions under extreme temperature (from -100 to +300C) and has dedicated workshops for hydrogenation, cyanidation, bromination. MINAKEM, with offices and production sites in Louvain-la-Neuve (BE), Dunkirk (FR) and Beuvry-la-Foret (FR) is an affiliate of the MINAFIN Group and as such has access to all technologies, resources, and capabilities to respond to its client’s needs, especially with MINASCENT technologies (Leuna, Germany), and PENNAKEM (Memphis, TN, USA).
Company type
Products and services
Custom Manufacturing, Excipients, Intermediates, Fine and Specialty Chemicals, APIs (Active Pharmaceutical Ingredients), Contract Services – Analytical & Lab Services
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Connect with Minakem on Facebook
Connect with Minakem on LinkedIn
Address
Minakem, 224 avenue de la Dordogne, BP 41 Dunkerque Cedex 2, Dunkerque, France, 59640
